1 rich Libsyn https://www.libsyn.com 300 600 🧬 Groundbreaking NEJM report! Two highly sensitized kidney transplant candidates (cPRA ~99.995–99.998%) underwent successful transplantation after dual CD19- and BCMA-targeted CAR-T therapy. 🎯 &amp;nbsp; Rather than simply removing antibodies, investigators targeted the cells that produce them—memory B cells and plasma cells. The result? Profound reduction in anti-HLA antibodies, successful transplantation, and no donor-specific antibody rebound during follow-up. 🚀 &amp;nbsp; This study expands the horizon of CAR-T beyond oncology and may herald a new era in transplant immunology. &amp;nbsp; 📖 NEJM 2026: Bhoj et al. #KidneyTransplant #CART #TransplantImmunology #PrecisionMedicine #MedicalInnovation #MedEd 🩺 Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity! http://www.MasterMedFacts.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41554585/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/202674290